According to RxSight's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.04. At the end of 2024 the company had a P/S ratio of 9.86.
Year | P/S ratio | Change |
---|---|---|
2024 | 9.86 | -39.28% |
2023 | 16.2 | 126.48% |
2022 | 7.17 | -47.38% |
2021 | 13.6 |